Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.

Plasma cholesterol lowering (PCL) slows and sometimes prevents progression of atherosclerosis and may even lead to regression. Little is known about how molecular processes in the atherosclerotic arterial wall respond to PCL and modify responses to atherosclerosis regression. We studied atherosclero...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johan L M Björkegren, Sara Hägg, Husain A Talukdar, Hassan Foroughi Asl, Rajeev K Jain, Cecilia Cedergren, Ming-Mei Shang, Aránzazu Rossignoli, Rabbe Takolander, Olle Melander, Anders Hamsten, Tom Michoel, Josefin Skogsberg
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Acceso en línea:https://doaj.org/article/91a3a9e28f764aec98649bad00f3c1b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:91a3a9e28f764aec98649bad00f3c1b0
record_format dspace
spelling oai:doaj.org-article:91a3a9e28f764aec98649bad00f3c1b02021-11-18T06:21:06ZPlasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.1553-73901553-740410.1371/journal.pgen.1004201https://doaj.org/article/91a3a9e28f764aec98649bad00f3c1b02014-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586211/pdf/?tool=EBIhttps://doaj.org/toc/1553-7390https://doaj.org/toc/1553-7404Plasma cholesterol lowering (PCL) slows and sometimes prevents progression of atherosclerosis and may even lead to regression. Little is known about how molecular processes in the atherosclerotic arterial wall respond to PCL and modify responses to atherosclerosis regression. We studied atherosclerosis regression and global gene expression responses to PCL (≥80%) and to atherosclerosis regression itself in early, mature, and advanced lesions. In atherosclerotic aortic wall from Ldlr(-/-)Apob (100/100) Mttp (flox/flox)Mx1-Cre mice, atherosclerosis regressed after PCL regardless of lesion stage. However, near-complete regression was observed only in mice with early lesions; mice with mature and advanced lesions were left with regression-resistant, relatively unstable plaque remnants. Atherosclerosis genes responding to PCL before regression, unlike those responding to the regression itself, were enriched in inherited risk for coronary artery disease and myocardial infarction, indicating causality. Inference of transcription factor (TF) regulatory networks of these PCL-responsive gene sets revealed largely different networks in early, mature, and advanced lesions. In early lesions, PPARG was identified as a specific master regulator of the PCL-responsive atherosclerosis TF-regulatory network, whereas in mature and advanced lesions, the specific master regulators were MLL5 and SRSF10/XRN2, respectively. In a THP-1 foam cell model of atherosclerosis regression, siRNA targeting of these master regulators activated the time-point-specific TF-regulatory networks and altered the accumulation of cholesterol esters. We conclude that PCL leads to complete atherosclerosis regression only in mice with early lesions. Identified master regulators and related PCL-responsive TF-regulatory networks will be interesting targets to enhance PCL-mediated regression of mature and advanced atherosclerotic lesions.Johan L M BjörkegrenSara HäggHusain A TalukdarHassan Foroughi AslRajeev K JainCecilia CedergrenMing-Mei ShangAránzazu RossignoliRabbe TakolanderOlle MelanderAnders HamstenTom MichoelJosefin SkogsbergPublic Library of Science (PLoS)articleGeneticsQH426-470ENPLoS Genetics, Vol 10, Iss 2, p e1004201 (2014)
institution DOAJ
collection DOAJ
language EN
topic Genetics
QH426-470
spellingShingle Genetics
QH426-470
Johan L M Björkegren
Sara Hägg
Husain A Talukdar
Hassan Foroughi Asl
Rajeev K Jain
Cecilia Cedergren
Ming-Mei Shang
Aránzazu Rossignoli
Rabbe Takolander
Olle Melander
Anders Hamsten
Tom Michoel
Josefin Skogsberg
Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
description Plasma cholesterol lowering (PCL) slows and sometimes prevents progression of atherosclerosis and may even lead to regression. Little is known about how molecular processes in the atherosclerotic arterial wall respond to PCL and modify responses to atherosclerosis regression. We studied atherosclerosis regression and global gene expression responses to PCL (≥80%) and to atherosclerosis regression itself in early, mature, and advanced lesions. In atherosclerotic aortic wall from Ldlr(-/-)Apob (100/100) Mttp (flox/flox)Mx1-Cre mice, atherosclerosis regressed after PCL regardless of lesion stage. However, near-complete regression was observed only in mice with early lesions; mice with mature and advanced lesions were left with regression-resistant, relatively unstable plaque remnants. Atherosclerosis genes responding to PCL before regression, unlike those responding to the regression itself, were enriched in inherited risk for coronary artery disease and myocardial infarction, indicating causality. Inference of transcription factor (TF) regulatory networks of these PCL-responsive gene sets revealed largely different networks in early, mature, and advanced lesions. In early lesions, PPARG was identified as a specific master regulator of the PCL-responsive atherosclerosis TF-regulatory network, whereas in mature and advanced lesions, the specific master regulators were MLL5 and SRSF10/XRN2, respectively. In a THP-1 foam cell model of atherosclerosis regression, siRNA targeting of these master regulators activated the time-point-specific TF-regulatory networks and altered the accumulation of cholesterol esters. We conclude that PCL leads to complete atherosclerosis regression only in mice with early lesions. Identified master regulators and related PCL-responsive TF-regulatory networks will be interesting targets to enhance PCL-mediated regression of mature and advanced atherosclerotic lesions.
format article
author Johan L M Björkegren
Sara Hägg
Husain A Talukdar
Hassan Foroughi Asl
Rajeev K Jain
Cecilia Cedergren
Ming-Mei Shang
Aránzazu Rossignoli
Rabbe Takolander
Olle Melander
Anders Hamsten
Tom Michoel
Josefin Skogsberg
author_facet Johan L M Björkegren
Sara Hägg
Husain A Talukdar
Hassan Foroughi Asl
Rajeev K Jain
Cecilia Cedergren
Ming-Mei Shang
Aránzazu Rossignoli
Rabbe Takolander
Olle Melander
Anders Hamsten
Tom Michoel
Josefin Skogsberg
author_sort Johan L M Björkegren
title Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
title_short Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
title_full Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
title_fullStr Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
title_full_unstemmed Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
title_sort plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/91a3a9e28f764aec98649bad00f3c1b0
work_keys_str_mv AT johanlmbjorkegren plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT sarahagg plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT husainatalukdar plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT hassanforoughiasl plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT rajeevkjain plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT ceciliacedergren plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT mingmeishang plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT aranzazurossignoli plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT rabbetakolander plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT ollemelander plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT andershamsten plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT tommichoel plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
AT josefinskogsberg plasmacholesterolinducedlesionnetworksactivatedbeforeregressionofearlymatureandadvancedatherosclerosis
_version_ 1718424494506246144